TY  - ADVS
AU  - SAILAJA,  L
TI  - Development and Evaluation of lovastain nanocrystals
U1  - 615.1 
PY  - 2014///
KW  - Pharmaceutics (615.1)
N1  - candesartan ; characterization ; Development ; Evaluation ; lovastain ; nanocrystals
ER  -